ID

12650

Beschreibung

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT; ODM derived from: https://clinicaltrials.gov/show/NCT00840853

Link

https://clinicaltrials.gov/show/NCT00840853

Stichworte

Versionen (1)
  1. 07.12.15 07.12.15 -
Hochgeladen am

7. Dezember 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

Englisch

Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
Beschreibung

any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)

Datentyp

boolean

Alias
UMLS CUI [1]
C2698589
UMLS CUI [2]
C0006413
UMLS CUI [3]
C1705576
or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b).
Beschreibung

or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b)

Datentyp

boolean

Alias
UMLS CUI [1]
C2698589
UMLS CUI [2]
C0023434
UMLS CUI [3]
C0024305
UMLS CUI [4]
C1705576
with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
Beschreibung

with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)

Datentyp

boolean

Alias
UMLS CUI [1]
C0543478
UMLS CUI [2]
C0277556
with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
Beschreibung

with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort

Datentyp

boolean

Alias
UMLS CUI [1]
C0153876
UMLS CUI [2]
C1705576
patients with life expectancy greater than or equal to 6 weeks
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patients with a karnofsky/lansky score greater than or equal to 50
Beschreibung

karnofsky/lansky score

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
donor hiv negative
Beschreibung

donor hiv negative

Datentyp

boolean

Alias
UMLS CUI [1]
C0481430
5. patient or parent/guardian capable of providing informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
Beschreibung

patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0428321
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0019046
pulse oximetry of greater than 90 percent on room air
Beschreibung

pulse oximetry

Datentyp

boolean

Alias
UMLS CUI [1]
C0034108
sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
Beschreibung

sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
Beschreibung

available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*

Datentyp

boolean

Alias
UMLS CUI [1]
C2981182
UMLS CUI [2]
C0201622
patients should have been off other investigational antiviral or antitumor therapy for one month prior to entry in this study.
Beschreibung

study subject participation status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers.
Beschreibung

note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers

Datentyp

boolean

Alias
UMLS CUI [1]
C0005771
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe intercurrent infection
Beschreibung

infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
evidence of graft versus host disease >grade ii
Beschreibung

graft versus host disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0018133
pregnant or lactating
Beschreibung

pregnant or lactating

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
history of hypersensitivity reactions to murine protein-containing products.
Beschreibung

history of hypersensitivity reactions to murine protein-containing products.

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
UMLS CUI [2]
C1699668
currently taking corticosteroids for therapy of gvhd.
Beschreibung

corticosteroids gvhd

Datentyp

boolean

Alias
UMLS CUI [1]
C0149783
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Acute Lymphoblastic Leukemia (ALL) NCT00840853

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
Item
any patient regardless of sex or age with cd19+ b-all undergoing allogeneic hsct (group a)
boolean
C2698589 (UMLS CUI [1])
C0006413 (UMLS CUI [2])
C1705576 (UMLS CUI [3])
or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b)
Item
or any patient regardless of sex or age with cd19+ b-cll or nhl undergoing allogeneic hsct (group b).
boolean
C2698589 (UMLS CUI [1])
C0023434 (UMLS CUI [2])
C0024305 (UMLS CUI [3])
C1705576 (UMLS CUI [4])
with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
Item
with minimal residual disease (mrd) or relapse post-hsct (for the phase i dose escalation)
boolean
C0543478 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
Item
with no evidence of all or cll/nhl post-hsct (to be included in the expansion cohort
boolean
C0153876 (UMLS CUI [1])
C1705576 (UMLS CUI [2])
life expectancy
Item
patients with life expectancy greater than or equal to 6 weeks
boolean
C0023671 (UMLS CUI [1])
karnofsky/lansky score
Item
patients with a karnofsky/lansky score greater than or equal to 50
boolean
C0206065 (UMLS CUI [1])
donor hiv negative
Item
donor hiv negative
boolean
C0481430 (UMLS CUI [1])
informed consent
Item
5. patient or parent/guardian capable of providing informed consent
boolean
C0021430 (UMLS CUI [1])
patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
Item
patients with bilirubin 2x normal or less, ast 3x normal or less, creatinine less than or equal to 2x normal for age and hgb greater than 8.0
boolean
C1278039 (UMLS CUI [1])
C0428321 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0019046 (UMLS CUI [4])
pulse oximetry
Item
pulse oximetry of greater than 90 percent on room air
boolean
C0034108 (UMLS CUI [1])
sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
Item
sexually active patients must be willing to utilize one of the more effective birth control methods for 6 months after the ctl infusion. the male partner should use a condom.
boolean
C0700589 (UMLS CUI [1])
available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
Item
available allogeneic cd19car transduced tri-virus-specific cytotoxic t lymphocytes with greater than or equal to 15 percent expression of cd19car determined by flow-cytometry and greater than 10 percent killing of one or more viral antigen pulsed targets in a cytotoxicity assay at an effector:target ratio of 20:1.*
boolean
C2981182 (UMLS CUI [1])
C0201622 (UMLS CUI [2])
study subject participation status
Item
patients should have been off other investigational antiviral or antitumor therapy for one month prior to entry in this study.
boolean
C2348568 (UMLS CUI [1])
note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers
Item
note: cell dose is based on total cell numbers and not individual antivirus or antileukemic cell numbers.
boolean
C0005771 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
infection
Item
severe intercurrent infection
boolean
C0009450 (UMLS CUI [1])
graft versus host disease
Item
evidence of graft versus host disease >grade ii
boolean
C0018133 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
history of hypersensitivity reactions to murine protein-containing products.
Item
history of hypersensitivity reactions to murine protein-containing products.
boolean
C0020517 (UMLS CUI [1])
C1699668 (UMLS CUI [2])
corticosteroids gvhd
Item
currently taking corticosteroids for therapy of gvhd.
boolean
C0149783 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video